SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-17-035969
Filing Date
2017-07-07
Accepted
2017-07-06 21:01:37
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 v470384_s3.htm S-3 194884
2 EXHIBIT 5.1 v470384_ex5-1.htm EX-5.1 15640
3 EXHIBIT 23.1 v470384_ex23-1.htm EX-23.1 2609
4 GRAPHIC logo_s3.jpg GRAPHIC 8962
5 GRAPHIC pg1img1_ex5-1.jpg GRAPHIC 7849
6 GRAPHIC pg1img2_ex5-1.jpg GRAPHIC 6830
7 GRAPHIC pg2img1_ex5-1.jpg GRAPHIC 5895
8 GRAPHIC pg3img1_ex5-1.jpg GRAPHIC 5895
  Complete submission text file 0001144204-17-035969.txt   263815
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-219188 | Film No.: 17953717
SIC: 2834 Pharmaceutical Preparations